Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,055.0
-68.2 (-2.18%)

 

  • STI Straits Times Index
    3,055.0
    -68.2 (-2.18%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,582.5
    4.9 (0.31%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,027.6
    308.9 (1.11%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,490.4
    60.8 (1.77%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,084.5
    636.5 (2.32%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,975.8
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,365.6M
  • Value: 3,210.3M
  • Rise: 58
  • Fall: 386
  • Unch: 328

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.007-0.002
Sembcorp Marine0.179-0.012
Oceanus^0.033-0.003
Genting Sing0.785-0.025
YZJ Shipbldg SGD1.410-0.050
Golden Agri-Res0.250-0.025
Singtel2.320-0.090
Frasers Property1.160-0.040
ThaiBev0.670-0.025
Jiutian Chemical0.091-0.007

World Indices

World Indices
Name Last Change
Nasdaq 13,125.0 +93.3
HSI 28,027.6 +308.9
HSCEI 10,405.0 +65.0
Jakarta 5,975.8
Nikkei 225 28,084.5 +636.5
SSE Comp 3,490.4 +60.8
Shanghai A 3,658.5 +63.8
Shanghai B 250.2 +2.5
KOSPI 3,153.3 +31.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

DPHARMA DUOPHARMA BIOTECH BERHAD
Quotes 15 Minutes Delayed. Updated at 12 May 2021 12:28
Last (MYR): 2.850 Change: +0.060 High: 2.870 Remarks: s
Remarks legend:
RemarksDescriptionRemarksDescription
IOrder entry forbiddenAOrder entry authorized
GFrozenSSuspended
RReservedsShort selling available
[x]Exclude dividend[c] Cum dividend
Change (%): +2.15 Low: 2.750
Open 2.790 Yesterday's Close 2.790
Buy Price 2.840 Sell Price 2.850
Buy Volume ('00) 8 Sell Volume ('00) 2,426
Cumulative Volume ('00) 17,044 Cumulative Value 4,823,485
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.08301 Trailing EPS (MYR) e 0.08875 NAV (MYR) b 0.9048
PE a 34.333 Trailing PE f 32.111 Price / NAV b 3.1499
Dividend (MYR) d 0.065000 Cash In Hand (MYR) g 0.2114 Issued & Paid-up Shares c 706,027,000
Dividend Yield (%) d 2.281 Price / Cash In Hand g 13.482 Treasury Shares h -
Beta - 75 Daysi -0.136 R-Squared - 75 Days(%)i 0.14 Market Cap (M) 2,012.177
Beta - 500 Daysi 0.555 R-Squared - 500 Days (%)i 2.74 Enterprise Value (M) 2,183.440
Piotroski F Score 5 Exchange Code 7148 Par Value ( MYR ) n.a.
52 Weeks Volatility (%) 56.27 6-Month VWAP 3.397 Free Float (%) 39.5
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Biotechnology
Index Components BM HEALTH CARE / FTSE Bursa Malaysia MID 70 Index / FTSE Bursa Malaysia Top 100 Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Aug 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference DPHARMA Bursa 2,012.177 34.333 32.111 3.1499 2.281
Industry Biotechnology Bursa 2,012.177 34.332 32.111 3.1500 2.281
PHARMACEUTICALS Bursa 782.906 26.602 26.983 2.6359 1.756
Index BM HEALTH CARE Bursa 9,403.577 23.201 10.089 3.4531 1.171
FTSE Bursa Malaysia MID 70 Index Bursa 5,554.187 53.025 43.919 1.3974 1.728
FTSE Bursa Malaysia Top 100 Index Bursa 14,126.754 30.223 24.053 1.6803 2.328
Global Peer AMGEN INC NASDAQ 144,827.827 19.938 20.441 15.5162 2.556
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 126,377.722 40.295 33.207 11.9593 1.057
Global Peer GILEAD SCIENCES INC NASDAQ 86,425.544 702.661 287.128 4.5602 3.947
Global Peer MODERNA INC NASDAQ 60,177.001 - 100.603 15.6792 -
Global Peer WUXI BIO HKEx 439,596.059 231.634 231.636 18.0296 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,487.927 20.463 20.090 6.1789 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 55,101.345 15.684 13.762 4.6006 -
Global Peer ILLUMINA INC NASDAQ 54,523.700 83.115 86.546 11.0776 -
Global Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 43,664.582 2,520.424 30.041 14.7451 -
Other Global Peers BIOGEN INC (NASDAQ), ALEXION PHARMACEUTICAL INC (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ZAI LAB-SB (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), EXELIXIS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GENSCRIPT BIO (HKEx), IONIS PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), JOINN (HKEx), TG THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), Lonza (SGX), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ALKERMES PLC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARVINAS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), KINTOR PHARMA-B (HKEx), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), 3SBIO (HKEx), AMICUS THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), NUVATION BIO INC (NYSE), ZENTALIS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), XENCOR INC (NASDAQ), ALPHAMAB-B (HKEx), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), INSTIL BIO INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), FIBROGEN INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), SORRENTO THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), SEER INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), OCUGEN INC (NASDAQ), VIVA BIOTECH (HKEx), REPLIMUNE GROUP INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), HAOHAI BIOTEC (HKEx), BIOATLA INC (NASDAQ), REGENXBIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ALLOVIR INC (NASDAQ), IMMUNOVANT INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), ASCENTAGE-B (HKEx), JW THERAP-B (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), PRECIGEN INC (NASDAQ), POLYNOVO LIMITED (ASX), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), EDGEWISE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), IMUGENE LIMITED (ASX), TRAVERE THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), SHATTUCK LABS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), CORTEXYME INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), VAXCYTE INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), RADIUS HEALTH INC (NASDAQ), JHBP-B (HKEx), EPIZYME INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD (ASX), DYNE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MERUS B V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PERSONALIS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), NKARTA INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), VAXART INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ANAPTYSBIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHEMOCENTRYX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ATHIRA PHARMA INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), IMMATICS N V (NASDAQ), ARDELYX INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), INHIBRX INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), IVERIC BIO INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), XBIOTECH INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), ASCLETIS-B (HKEx), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), GERON CORP (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), SINOMAB BIO-B (HKEx), APTOSE BIOSCIENCES INC (NASDAQ), ADICET BIO INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), CUE BIOPHARMA INC (NASDAQ), ESSEX BIO-TECH (HKEx), PUMA BIOTECHNOLOGY INC (NASDAQ), SESEN BIO INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), ONCORUS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED (ASX), FOGHORN THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), PARATEK PHARMACEUTICALS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), SELECTA BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), XOMA CORP (NASDAQ), ATRECA INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), SYROS PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), KAMADA LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), NEXT SCIENCE LTD (ASX), ARBUTUS BIOPHARMA CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), IMMUTEP LTD (ASX), INFINITY PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CHIASMA INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), MEDICINOVA INC (NASDAQ), NANOVIRICIDES INC (NYSE American), CEL-SCI CORP (NYSE American), IMMUNOME INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), BIOVIE INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), BIONOMICS LTD (ASX), SYNLOGIC INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ENZO BIOCHEM INC (NYSE), ONCOLYTICS BIOTECH INC (NASDAQ), CONTRAFECT CORP (NASDAQ), INMUNE BIO INC (NASDAQ), IBIO INC (NYSE American), CATALYST BIOSCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), BIOMX INC (NYSE American), GLYCOMIMETICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), OTONOMY INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), MINERVA NEUROSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), RECRO PHARMA INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), LONGEVERON INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), LA JOLLA PHARMACEUTICAL CO (NASDAQ), AIM IMMUNOTECH INC (NYSE American), TRACON PHARMACEUTICALS INC (NASDAQ), METACRINE INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LEAF RESOURCES LTD (ASX), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), UNI-BIO GROUP (HKEx), AIKIDO PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CAPRICOR THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), COHBAR INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), PRECIPIO INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), REGENT PACIFIC (HKEx), ALIMERA SCIENCES INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ATYR PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), BIOCARDIA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CT ENTERPRISE (HKEx), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), CYCLO THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), BENITEC BIOPHARMA INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ADITX THERAPEUTICS INC (NASDAQ), PALISADE BIO INC (NASDAQ), MEMPHASYS LTD (ASX), Suntar Eco-City (SGX), HISTOGEN INC (NASDAQ), GEOVAX LABS INC (NASDAQ), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), BIOSINO BIO-TEC (HKEx), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ADALTA LTD (ASX), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CONSTELLATION TECHNOLOGIES LTD (ASX), SENESTECH INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days --0.060
-2.06 %
20 Days 0.060-0.030
+1.04 %
Medium Term Return 3 Months 0.060-0.540
-14.16 %
6 Months 0.060-1.150
-27.25 %
1 Year 0.115+1.120
+71.39 %
Long Term Return 2 Years 0.165+1.550
+131.92 %
3 Years 0.240+1.474
+124.56 %
5 Years 0.385+1.821
+214.38 %
Annualised Return Annualised --
+25.75 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.560 - 4.380 Change From 1 Year Low +1.290 % Change From 1 Year Low (%) +82.69
Change From 1 Year High -1.530 % Change From 1 Year High (%) -34.93
2 Years Range 1.050 - 4.380 Change From 2 Years Low +1.800 % Change From 2 Years Low (%) +171.43
Change From 2 Years High -1.530 % Change From 2 Years High (%) -34.93
5 Years Range 0.814 - 4.380 Change From 5 Years Low +2.036 % Change From 5 Years Low (%) +249.99
Change From 5 Years High -1.530 % Change From 5 Years High (%) -34.93
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

CCM Duopharma Biotech Berhad, an investment holding company, engages in the manufacture, distribution, import, and export of pharmaceutical products and medicines in Malaysia. It offers various over the counter products, including analgesic/anti-pyretics, antibacterial mouthwash, childrens vitamins, cough preparations, dermatology products, eye drops, first aid dressings, and health suppliments. The company provides its products in various forms, such as tablets, capsules, syrup, oral antibiotic, creams, haemodialysis solution, sterile irrigation solution, sterile powder injectables, small volume injectables, dental cartridges, and eye drop preparations. It exports its products to various countries, including Vietnam, Ethiopia, Sudan, South East Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore, and Hong Kong. The company was founded in 1979 and is based in Klang, Malaysia. CCM Duopharma Biotech Berhad is a subsidiary of CCM Marketing Sdn. Bhd.

IPO Performance

Listing Date 18 Jul 2002 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 7.50 Public Offer Subscription Rate (x) -
IPO Price (MYR) 2.100 First Day Close (MYR) 1.043 First Week Close (MYR) 1.006
Current vs IPO Price (%) +35.71 First Day Gain (%) -50.33 First Week Gain (%) -52.10

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(2.89 MB)
Part 2(2.98 MB)
Annual Report 2018 Dec 2018 Part 1(2.61 MB)
Part 2(2.17 MB)
Annual Report 2018 Apr 2018 Part 1(1.46 MB)
Part 2(0.88 MB)
Part 3(0.27 MB)
Part 4(2.43 MB)
Part 5(1.63 MB)
Annual Report 2016 Dec 2016 Part 1(2.85 MB)
Part 2(0.73 MB)
Annual Report 2015 Dec 2015 Part 1(0.08 MB)
Part 2(2.44 MB)
Part 3(0.02 MB)
Part 4(0.04 MB)
Annual Report 2014 Dec 2014 Part 1(2.20 MB)
Annual Report 2013 Dec 2013 Part 1(1.34 MB)
Annual Report 2012 Dec 2012 Part 1(1.64 MB)
Annual Report 2011 Dec 2011 Part 1(1.12 MB)
Part 2(0.11 MB)
Annual Report 2010 Dec 2010 Part 1(2.37 MB)
Annual Report 2009 Dec 2009 Part 1(2.87 MB)
Part 2(0.15 MB)
Annual Report 2008 Dec 2008 Part 1(0.82 MB)
Annual Report 2007 Dec 2007 Part 1(0.04 MB)
Part 2(2.16 MB)
Annual Report 2006 Dec 2006 Part 1(1.01 MB)
Part 2(0.02 MB)
Annual Report 2005 Dec 2005 Part 1(0.30 MB)
Part 2(0.82 MB)
Annual Report 2004 Dec 2004 Part 1(0.52 MB)
Part 2(1.35 MB)
Annual Report 2003 Dec 2003 Part 1(0.63 MB)
Annual Report 2002 Dec 2002 Part 1(1.12 MB)
Part 2(0.42 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
12 May 2021 2.790 2.870 2.750 2.850 1,704,400 2.8300
11 May 2021 2.870 2.870 2.780 2.790 1,417,100 2.7990
10 May 2021 2.850 2.920 2.840 2.870 2,881,800 2.8667
07 May 2021 2.800 2.880 2.780 2.840 2,668,700 2.8475
06 May 2021 2.880 2.880 2.770 2.820 1,086,500 2.8101
05 May 2021 2.930 2.930 2.820 2.850 2,607,800 2.8587
04 May 2021 2.980 3.020 2.890 2.920 5,634,800 2.9384
03 May 2021 2.890 2.950 2.880 2.930 6,638,800 2.9094
30 Apr 2021 2.920 2.930 2.830 2.850 2,811,300 2.8745
28 Apr 2021 2.870 2.950 2.830 2.910 9,193,100 2.9126
27 Apr 2021 2.700 2.870 2.670 2.850 2,567,400 2.7982
26 Apr 2021 2.610 2.730 2.600 2.660 2,233,700 2.6774
23 Apr 2021 2.630 2.660 2.560 2.600 1,895,300 2.6129
22 Apr 2021 2.610 2.660 2.610 2.610 398,700 2.6349
21 Apr 2021 2.630 2.710 2.600 2.600 994,800 2.6464
20 Apr 2021 2.750 2.750 2.630 2.680 4,585,900 2.6983
19 Apr 2021 2.840 2.840 2.750 2.760 533,000 2.7796
16 Apr 2021 2.880 2.880 2.800 2.830 687,600 2.8446
15 Apr 2021 2.880 2.880 2.820 2.880 623,000 2.8567
14 Apr 2021 2.810 2.880 2.790 2.880 1,431,600 2.8649
13 Apr 2021 2.800 2.810 2.790 2.810 557,500 2.8005
12 Apr 2021 2.900 2.920 2.770 2.800 1,549,000 2.8234
Summary
Current 2 Weeks
(28 Apr 2021 to 12 May 2021)
2.870 3.020 2.750 2.850 36,644,300 -
Previous 2 Weeks
(14 Apr 2021 to 27 Apr 2021)
2.810 3.020 2.750 2.850 15,951,000 -
4 Weeks from
(17 Mar 2021 to 13 Apr 2021)
2.630 3.020 2.590 2.810 25,337,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.